The Words Left Behind

KATE KUP Tennis Tournament Presented by Harbor View Private Wealth Raises More Than $90,000 for Pediatric Cancer Research 

April 10, 2026

 JACKSONVILLE, Fla. (April 10, 2026) – The Kate Amato Foundation raised more than $90,000 at the seventh annual KATE KUP Triples Tennis Tournament, held March 28 at The Yards in Ponte Vedra Beach. The event brought together players, volunteers, supporters, and local businesses for a high-energy day of fun and fundraising, with Harbor View Private Wealth serving as the tournament’s title sponsor. All net proceeds from the event benefit Kate Amato Foundation (KAF), whose mission is to fund innovative pediatric cancer research that accelerates the pace of progress and saves young lives.  The KATE KUP Triples Tennis Tournament is the only event of its kind in the Jacksonville area and is held annually at The Yards Tennis Center…

Kate Amato Foundation Launches One Million, One Mission Campaign to Reach $1 Million in Research Grants Funded for Pediatric Cancer Research

October 2, 2025

As September concludes and Childhood Cancer Awareness Month comes to a close, Kate Amato Foundation (KAF) is shining a light on the power of kindness and the urgency of research, aiming to raise an additional $75,000 by November 30, 2025, to hit the $1 million milestone in total grant funding at some of the nation’s leading pediatric cancer research centers. At the same time, the Foundation remains committed to Kate’s Kindness Project, which delivered care packages to Wolfson Children’s Hospital and Nemours Children’s Health in September – a tradition since 2020 that brings comfort and hope to young patients, their families and healthcare heroes. Together, these efforts reflect Kate’s legacy: Uplifting children today while funding the life-saving research…

Dear Pfizer

February 19, 2025

Dear Pfizer, Let’s talk about pediatric cancer. The Super Bowl commercial announcing the Knock-Out Cancer campaign caught everyone’s attention. It was heart-warming and inspiring. But for those of us in the child cancer community, it was triggering. Pediatric cancer has not been a national priority, receiving relatively little attention and financial investment from the National Cancer Institute or the Pharmaceutical Industry in comparison to adult cancers. That said, some of us were suspicious of the ad. But many of us felt a glimmer of hope, believing maybe something was beginning to change and finally a major pharmaceutical company was stepping up to fight for our children in a big way. After all, it was a $16M advertising space…